Supplementary experimental procedures

Bacterial strains and growth conditions
All bacterial strains used in this study are summarized in Table S1 . Strain MC4100 [F -araD139
Δ(argF-lac) U169 rpsL150 relA1 flbB5301 ptsF25 deoC1 ptsF25 thi] (Casadaban, 1976) was used for all experiments. Deletion mutants were generated by P1 transduction using BW25113
[F -∆(araD-araB)567 ∆lacZ4787::rrnB-3 λ -rph-1 ∆(rhaD-rhaB)568 hsdR514] mutant strains from the Keio collection (Datsenko and Wanner, 2000; Baba et al., 2006) . To generate mutants with multiple gene deletions, the initial resistance cassette marker used to transduce the first mutation was removed using pCP20 plasmid and cured as previously described (Cherepanov and Wackernagel, 1995; Datsenko and Wanner, 2000) . Luria-Bertani (LB) broth (1% tryptone and 0.5% yeast extract, supplemented with or without 1% NaCl) and agar were prepared as previously described (Silhavy et al., 1984) . Unless otherwise noted, ampicillin (Amp) was used at a concentration of 200 μg mL -1 , chloroamphenicol (Cam) at 30 μg mL -1 , and kanamycin (Kan)
at 25 μg mL -1 .
Plasmid construction
All plasmids are listed in Table S2 . To construct pACYC184His, coding sequence for the octahistidine tag was inserted into pACYC184 via site-directed mutagenesis using pACYC184-N-FWD/pACYC184-C-REV primer pair. FWD/dMlaA-C-XhoI-REV was used to amplify the DNA fragment from the MC4100 DNA template. PCR fragment was digested with NcoI/XhoI and inserted into the same restriction sites of the pET22b(+) (Novagen). The dmlaA DNA fragment containing N-terminal pelB signal sequence was later digested from the pET22b(+) using restriction enzymes NdeI/XhoI and ligated into same restriction sites of the pET23/42. Primer sequences are given in Table S3 .
OM protein isolation and analyses
OM proteins were isolated from the cells as previously described (Mecsas et al., 1993) with some modifications. 10-mL cultures were grown (inoculated with overnight cultures at 1:100 dilution) in LB broth (supplemented with or without 1% NaCl) at 37°C until OD 600 reached ~0.5-0.7 (exponential) or ~2-4 (stationary, after 13-14 h). Equal amounts of cells for each strain (normalized by OD 600 ) were harvested by centrifugation at 4,700 x g for 20 min. Cells were resuspended with 1 mL 100 mM Tris.HCl pH 8.0 containing 100 μg mL -1 lysozyme, 10 mM EDTA pH 8.0 and incubated at 4°C for 20 min. The resuspended cells were supplemented with 10 mM MgCl 2 , 50 μg mL -1 DNase I and 1 mM PMSF, followed by three cycles of freeze-thaw to lyse the cells. The cell lysate was collected and centrifuged at 21,000 x g for 1 h. The membrane pellet was extracted with 1 mL of 20 mM sodium phosphate, pH 7.0 containing 0.5% sarkosyl (Sigma) at 4°C for 1 h, by rocking, and centrifuged as above. The pellet was washed once with 1 mL of 20 mM sodium phosphate, pH 7.0 containing 0.5% sarkosyl and recentrifuged as above.
Finally, the insoluble OM materials were mixed with equal amounts of 2X Laemmli reducing buffer and subjected to SDS-PAGE analyses and immunoblotting.
SDS-PAGE and immunoblotting
All samples subjected to SDS-PAGE were mixed with equal amounts of 2X Laemmli reducing buffer before boiling for 10 min at 100°C. Equal volumes of the samples were loaded onto the gels. Unless otherwise stated, SDS-PAGE was performed according to Laemmli using the 4-20%
Tris.HCl gradient gels (Laemmli, 1970) . 11% Tris.HCl gels with 6 M urea was used to resolve OM proteins (OmpA, OmpC and OmpF). After SDS-PAGE, gels were either stained with the 0.25% Coomassie blue G250 (Sigma) or subjected to immunoblotting.
Immunoblotting was performed by transferring protein bands from the gels onto polyvinylidene fluoride (PVDF) membranes (Immun-Blot ® 0.2 μm, Bio-Rad) using semi-dry electroblotting system (Trans-Blot ® Turbo TM Transfer System, Bio-Rad). Membranes were blocked by 1X casein blocking buffer (Sigma). α-His antibody (pentahistidine) conjugated to the horseradish peroxidase (HRP) (Qiagen) was used at a dilution of 1:5,000. Monoclonal α-MlaA antibody was developed against the MlaA VGKWTLEGIETRAQ peptide sequence (a.a. 182-195 of MlaA) and used at 1:3,000 dilution. Immunization of mice was performed by Abmart (China). Monoclonal α-OmpC antibody was a gift from Swaine Chen and used at a dilution of 1:3,000 (Khetrapal et al., 2015) . Both α-LptB (Natividad Ruiz) (Sherman et al., 2014) and α-LptE (Daniel Kahne) (Chng et al., 2010) antisera were used at 1:10,000 dilution. α-OmpF antiserum was provided by Rajeev Misra and used a dilution of 1:20,000 (Charlson et al., 2006) . Figure S1 . Expression levels of OmpC and OmpF vary with osmolarity. OM proteins isolated from wild-type (WT) and indicated mutant strains grown under (A) high osmolarity and (B) low osmolarity conditions were subjected to SDS-PAGE followed by Coomassie blue staining. 11%
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Tris.HCl SDS-PAGE gels containing 6 M urea were used to resolve OmpC, OmpF and OmpA.
The respective osmolarity value (range) for each condition is indicated (personal communication,
Leslie Morgan and Linda Kenney). Samples were obtained from cells in exponential (top panels)
and stationary phase (bottom panels). Positions of relevant molecular weight markers are indicated in kDa. 
